Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The management of primary small bowel and colon lymphoma--a review.
Int J Colorectal Dis. 2012 May;27(5):555-63. doi: 10.1007/s00384-011-1309-2. Epub 2011 Sep 13.
Int J Colorectal Dis. 2012.
PMID: 21912877
Review.
AIMS: The management of primary small bowel and colon lymphoma is controversial. A review of the literature was therefore undertaken to evaluate the evidence for the classification, staging, diagnosis, and treatment of primary small bowel and colon lymphom …
AIMS: The management of primary small bowel and colon lymphoma is controversial. A review of the literature was therefore unde …
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment.
Al-Hatamleh MAI, E A R ENS, Boer JC, Ferji K, Six JL, Chen X, Elkord E, Plebanski M, Mohamud R.
Al-Hatamleh MAI, et al.
Cells. 2019 Dec 20;9(1):33. doi: 10.3390/cells9010033.
Cells. 2019.
PMID: 31877663
Free PMC article.
Tumor necrosis factor receptor 2 (TNFR2) is expressed on some tumor cells, such as myeloma, Hodgkin lymphoma, colon cancer and ovarian cancer, as well as immunosuppressive cells. ...From an epigenetic perspective, previous studies indicate that DNA demethylation mig …
Tumor necrosis factor receptor 2 (TNFR2) is expressed on some tumor cells, such as myeloma, Hodgkin lymphoma, colon cancer and …
Item in Clipboard
Cite
Cite